Trial · NCT07887633
SONATA Dose Duration LIFU for OCD
NCT07887633, Phase 2, Recruiting, University of Pennsylvania
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. SONATA Dose Duration LIFU for OCD. Trials, record NCT07887633. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887633
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- SONATA Dose Duration LIFU for OCD
- NCT number
- NCT07887633
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 20 participants, estimated
- Lead sponsor
- University of Pennsylvania
- Conditions
- Obsessive - Compulsive Disorder
- Interventions
- ATTN201 - Low Intensity Focused Ultrasound
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participant Report of Symptoms | 4 weeks | The 22-item Participant Report of Symptoms questionnaire provides granular, visit-level characterization of tolerability and symptomatic response across the treatment course, complementing the primary tolerability endpoints. |
| Primary | Visual Analog Scale | 4 weeks | The Visual Analog Scale, which assesses on a scale from 0-10 the participants obsessions, compulsions, distress, depression, energy and anxiety. This survey provides granular, visit-level characterization of tolerability and symptomatic response across the treatment course, complementing the primary tolerability endpoints. |
| Primary | Beck Depression Inventory | 4 weeks | The Beck Depression Inventory (BDI-II)allows for monitoring of unintended effects on mood, given that the STN plays a role in emotional processing and provide a broader characterization of the clinical impact of treatment. The BDI-II is an assessment used to measure severity of depression |
| Primary | Becks Anxiety Inventory | 4 weeks | The Becks Anxiety Inventory (BAI) allows for monitoring of unintended effects on anxiety, given that the STN plays a role in emotional processing and provide a broader characterization of the clinical impact of treatment. The BAI is an assessment used to measure clinical anxiety. |
| Primary | Clinical Global Impression Scale | 4 weeks. | The Clinical Global Impression scale asks two questions; the severity of illness and the change in illness. This scale allows a clinician completed score to monitor unintended effects on mood and anxiety. The Clinical Global Impressions - Improvement (CGI-I) scale is used to measure how much a patient's illness has improved or worsened. The Clinical Global Impressions - Severity (CGI-S) is used to measure how severe the patient's illness is. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers11
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887633
GET https://conductscience.org/api/trials/v1/NCT07887633/registered